Literature DB >> 12602762

Current status of selective estrogen receptor modulators (SERMs).

Suzanne D Conzen1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12602762     DOI: 10.1097/00130404-200301000-00003

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  5 in total

1.  Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.

Authors:  Hong Liu; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

2.  Structural modulation of oxidative metabolism in design of improved benzothiophene selective estrogen receptor modulators.

Authors:  Zhihui Qin; Irida Kastrati; Rezene T Ashgodom; Daniel D Lantvit; Cassia R Overk; Yongsoo Choi; Richard B van Breemen; Judy L Bolton; Gregory R J Thatcher
Journal:  Drug Metab Dispos       Date:  2008-10-20       Impact factor: 3.922

Review 3.  The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response.

Authors:  Francisco J Quintana
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

4.  Raloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cells.

Authors:  Irida Kastrati; Praneeth D Edirisinghe; L-P-Madhubani P Hemachandra; Esala R Chandrasena; Jaewoo Choi; Yue-Ting Wang; Judy L Bolton; Gregory R J Thatcher
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

5.  Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia.

Authors:  Lifeng Feng; Jiaqiu Li; Lixian Yang; Libo Zhu; Xiufeng Huang; Shuzheng Zhang; Likang Luo; Zhinong Jiang; Tingting Jiang; Wenxia Xu; Xian Wang; Hongchuan Jin
Journal:  Theranostics       Date:  2017-04-10       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.